Tirzepatide Quick Start Guide: Get Started in 5 Steps

    3 min read
    Recently Updated

    Tirzepatide is one of the most effective weight loss medications available. Here's how to start treatment in 5 simple steps.

    Step 1: Confirm Eligibility

    You qualify if:

    • BMI ≥30 (obese), OR
    • BMI ≥27 with conditions (diabetes, hypertension, etc.)
    • Age 18 or older
    • Committed to weight loss journey

    Cannot use if:

    • Pregnant, planning pregnancy, or breastfeeding
    • Personal/family history of medullary thyroid carcinoma
    • Multiple Endocrine Neoplasia syndrome type 2
    • History of severe pancreatitis

    Step 2: Choose Your Provider

    Online Services (Recommended):

    • Timeline: Start within 3-7 days
    • Cost: $300-$500/month (all-inclusive)
    • Includes: Consultation + medication + shipping
    • Best for: Quick start, convenience

    Traditional Doctor:

    • Timeline: 1-4 weeks
    • Cost: Varies with insurance
    • May require: Multiple appointments
    • Best for: Insurance coverage available

    Step 3: Medical Consultation

    What happens:

    • Complete health questionnaire (15 minutes)
    • Provide current medications and medical history
    • Discuss weight loss goals and expectations
    • Doctor reviews for approval
    • Ask questions about treatment

    Step 4: Receive Your Prescription

    After approval:

    • Prescription sent to pharmacy same day
    • Medication prepared and shipped
    • Delivery within 3-7 business days
    • Includes: Tirzepatide vials, syringes, alcohol swabs, sharps container, injection guide

    Step 5: Begin Treatment

    Your first injection:

    • Dose: Start with 1.5mg once weekly
    • Location: Inject into abdomen, thigh, or upper arm
    • Timing: Same day/time each week
    • Storage: Refrigerate between 36-46°F

    Week-by-Week Guide: Your First Month on Tirzepatide

    Knowing what to expect during each week of your first month helps you prepare mentally and physically. The initial weeks are when your body adjusts to the medication, and having realistic expectations prevents unnecessary anxiety about normal adjustment symptoms.

    Week 1: Getting Started

    Your first injection at the 2.5mg dose marks the beginning of your treatment journey. Within the first 24-48 hours, most patients notice a subtle reduction in appetite and food noise. You may feel slightly queasy, particularly around meals, but this is typically mild at the starting dose. Focus on eating regular, balanced meals even if your appetite is reduced, prioritizing protein at each meal. Stay well hydrated with at least 64 ounces of water daily. Most patients lose 1-2 pounds in the first week, though some of this is water weight related to reduced food intake and lower carbohydrate consumption.

    Week 2: Finding Your Rhythm

    By your second injection, you are beginning to establish the weekly routine that will become second nature over time. Appetite reduction becomes more noticeable, and you may find that portions that previously felt normal now feel too large. This is the medication working as intended. Continue focusing on protein-first eating and adequate hydration. Some patients experience constipation during the second week as gastric emptying slows. If this occurs, increase fiber intake gradually and ensure you are drinking enough water. Weight loss typically continues at 1-2 pounds per week.

    Week 3: Adjustment Period

    The third week often represents peak side effects at the starting dose, though for most patients these remain mild. Your body is adapting to the medication's effects on gastric emptying and appetite signaling. Energy levels may fluctuate as your caloric intake decreases. This is a good time to establish an exercise routine if you have not already, starting with moderate activities like walking for 20-30 minutes most days. Resistance training two to three times per week helps preserve lean muscle mass during weight loss.

    Week 4: Preparing for Dose Escalation

    By the end of your fourth week, most patients have adapted well to the starting dose. Side effects have typically diminished, appetite reduction feels manageable, and a pattern of steady weight loss is emerging. Total weight loss at four weeks averages 5-10 pounds, though individual results vary widely based on starting weight, diet quality, and activity level. Your provider will assess your tolerance and, if you have managed the starting dose well, will increase your dose to the next level. Prepare for a brief recurrence of mild side effects with the dose increase, applying the same management strategies that worked during the initial weeks.

    Injection Technique: Step-by-Step

    Proper injection technique is important for both comfort and medication effectiveness. While the process may seem intimidating at first, most patients become comfortable within two to three injections. Taking time to learn and practice correct technique from the beginning prevents common issues like injection site reactions, bruising, and inconsistent medication delivery.

    Begin by removing the medication from the refrigerator 15-30 minutes before your scheduled injection time. Allowing the medication to reach room temperature significantly reduces injection discomfort. While waiting, wash your hands thoroughly with soap and water and gather your supplies: medication vial, syringe, alcohol swab, and sharps container. Select your injection site, rotating between the abdomen (at least two inches from the navel), front of the thigh, and back of the upper arm. Each week, use a different area within these regions to prevent skin irritation and ensure consistent absorption.

    Clean the injection site with the alcohol swab using a circular motion and allow it to dry completely. Draw up the prescribed dose following the instructions provided with your supplies. Pinch a fold of skin at the injection site, insert the needle at a 90-degree angle in a quick, firm motion, and inject the medication slowly and steadily over 5-10 seconds. Do not rush the injection, as slow administration reduces discomfort and local reactions. After injecting the full dose, count to five before withdrawing the needle, then release the skin fold. Apply gentle pressure with a cotton ball or gauze if needed, but do not rub the injection site. Dispose of the needle immediately in your sharps container.

    Side Effect Management for New Starters

    Managing side effects effectively during the first weeks of treatment is critical for long-term success because early side effects are the most common reason patients discontinue treatment prematurely. The good news is that most side effects are predictable, temporary, and manageable with straightforward strategies.

    Nausea is the most frequently reported side effect, affecting approximately 25-30% of patients during the initial weeks. The most effective management approach combines dietary modifications with strategic timing. Eat five to six small meals throughout the day rather than three large ones. Focus on bland, low-fat foods during the first few days after each injection: crackers, plain rice, baked chicken, broth-based soups, and bananas. Avoid fried foods, heavy sauces, and large volumes of liquid with meals. Many patients find that scheduling their injection for the evening allows them to sleep through the peak nausea period.

    Constipation affects approximately 15-20% of new patients and tends to develop gradually as gastric emptying slows. Proactive management is more effective than reactive treatment. Increase your fiber intake through fruits, vegetables, and whole grains, but do so gradually to avoid worsening bloating. Drink at least 64 ounces of water daily, as dehydration exacerbates constipation. Light physical activity, particularly walking after meals, stimulates intestinal motility. If dietary measures are insufficient, over-the-counter stool softeners such as docusate sodium are safe and effective. Avoid stimulant laxatives unless recommended by your provider.

    Diet Tips for New Tirzepatide Users

    Nutrition during the first months of tirzepatide treatment lays the foundation for both weight loss results and long-term health. While the medication reduces appetite and makes it easier to eat less, the quality of what you eat matters enormously for preserving muscle mass, maintaining energy, preventing nutrient deficiencies, and establishing sustainable eating patterns.

    Protein should be your dietary priority. Aim for 25-30 grams of protein at each meal, targeting a daily total of 1.0-1.2 grams per kilogram of your goal body weight. Adequate protein intake preserves lean muscle mass during weight loss, which is critical for maintaining metabolic rate and long-term weight maintenance. Good protein sources include lean poultry, fish, eggs, Greek yogurt, cottage cheese, legumes, and tofu. If you struggle to meet protein targets due to reduced appetite, protein shakes or supplements can help bridge the gap, particularly on days when solid food feels unappealing.

    Hydration requires deliberate attention because tirzepatide can reduce thirst along with hunger. Dehydration worsens many common side effects including constipation, fatigue, and headaches. Set a goal of at least 64 ounces of water daily, and track your intake using a marked water bottle or smartphone app. Sip water throughout the day rather than drinking large amounts at meals, which can worsen feelings of fullness and bloating. Electrolyte-enhanced beverages or adding a pinch of salt and squeeze of citrus to your water can support hydration, particularly if you are experiencing diarrhea.

    Dosage Progression

    Tirzepatide is gradually increased for tolerance:

    • Weeks 1-4: 1.5mg weekly
    • Weeks 5-8: 3mg weekly
    • Weeks 9-12: 6mg weekly
    • Weeks 13-16: 9mg weekly
    • Weeks 17-20: 11mg weekly
    • Week 21+: 13.5mg (maximum dose)

    Expected Results Timeline

    • Week 1-2: Reduced appetite, 1-3 lbs loss
    • Month 1: 5-10 lbs loss
    • Month 3: 10-20 lbs loss
    • Month 6: 15-25 lbs loss (12-15% body weight)
    • Month 12: 25-45 lbs loss (18-22% body weight)

    Tips for Success

    • Stay hydrated (64+ oz water daily)
    • Eat protein-rich foods to preserve muscle
    • Exercise 150+ minutes weekly
    • Get adequate sleep (7-9 hours)
    • Track weight and side effects
    • Attend all follow-up appointments

    Ready to Start Tirzepatide?

    Trimi offers tirzepatide with doctor consultation, free shipping, and ongoing support. Start your transformation today.

    Begin Your Journey

    Frequently Asked Questions

    Is tirzepatide better than semaglutide?

    Tirzepatide typically produces slightly more weight loss (20-22% vs 15-17% with semaglutide) due to its dual GIP/GLP-1 mechanism. However, individual results vary.

    Can I switch from semaglutide to tirzepatide?

    Yes, many people switch. Your doctor will determine the appropriate starting dose of tirzepatide based on your current semaglutide dose.

    How quickly does tirzepatide work?

    Appetite reduction begins within days. Noticeable weight loss typically starts by week 3-4, with significant results by month 3-6.

    Related Articles

    Guide

    Tirzepatide Dosage Guide: Starting, Titrating, and Maintenance

    Complete dosing guide for tirzepatide treatment.

    Read more
    Guide

    First Month on Tirzepatide: What to Expect

    Complete guide to your first month including side effects and tips.

    Read more
    Comparison

    Tirzepatide vs Semaglutide: Which is Better for Weight Loss?

    In-depth comparison of the two most effective GLP-1 medications.

    Read more

    Related Reading

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.

    What does the published clinical evidence show for compounded tirzepatide?

    Peer-reviewed evidence: Tirzepatide 15 mg produced a mean body weight reduction of approximately 22.5% at 72 weeks in adults with obesity without diabetes; the 5 mg and 10 mg doses produced 16.0% and 21.4% reductions respectively. (Source: SURMOUNT-1, NEJM 2022). Trimi offers compounded tirzepatide starting at $125/month on the annual plan, dispensed by 503A community sterile compounding pharmacies (VialsRx — Texas pharmacy license #35264 — and GreenwichRx). Results vary by individual; eligibility is determined by a licensed clinician.

    Tirzepatide 15 mg produced a mean body weight reduction of approximately 22.5% at 72 weeks in adults with obesity without diabetes; the 5 mg and 10 mg doses produced 16.0% and 21.4% reductions respectively. — SURMOUNT-1, NEJM 2022
    In a 40-week head-to-head trial of patients with type 2 diabetes, tirzepatide 15 mg produced approximately 11.2 kg of body-weight reduction vs 5.7 kg on semaglutide 1 mg. — SURPASS-2, NEJM 2021
    Tirzepatide reduced the apnea-hypopnea index by approximately 27 to 30 events/hour at 52 weeks in adults with obesity and moderate-to-severe obstructive sleep apnea, vs roughly 5 events/hour reduction on placebo. — SURMOUNT-OSA, NEJM 2024

    Key Takeaways

    • Tirzepatide 15 mg produced a mean body weight reduction of approximately 22.5% at 72 weeks in adults with obesity without diabetes; the 5 mg and 10 mg doses produced 16.0% and 21.4% reductions respectively. (Source: SURMOUNT-1, NEJM 2022)
    • In a 40-week head-to-head trial of patients with type 2 diabetes, tirzepatide 15 mg produced approximately 11.2 kg of body-weight reduction vs 5.7 kg on semaglutide 1 mg. (Source: SURPASS-2, NEJM 2021)
    • Tirzepatide reduced the apnea-hypopnea index by approximately 27 to 30 events/hour at 52 weeks in adults with obesity and moderate-to-severe obstructive sleep apnea, vs roughly 5 events/hour reduction on placebo. (Source: SURMOUNT-OSA, NEJM 2024)
    • Tirzepatide is the active pharmaceutical ingredient; it is FDA-approved in the corresponding brand finished products (Zepbound and Mounjaro). Trimi's compounded preparation of the same active ingredient is prepared per individual prescription by 503A community sterile compounding pharmacies and is not itself FDA-approved as a drug.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: November 26, 2025

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    Robyn Lynn CurtisFacebook
    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2206038
    2. Frías JP, Davies MJ, Rosenstock J, et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2107519
    3. Wadden TA, Chao AM, Machineni S, et al. (2023). Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nature Medicine.Read StudyDOI: 10.1038/s41591-023-02597-w
    4. Aronne LJ, Sattar N, Horn DB, et al. (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA.Read StudyDOI: 10.1001/jama.2023.24945
    5. Malhotra A, Grunstein RR, Fietze I, et al. (2024). Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2404881
    6. U.S. Food and Drug Administration (2024). Zepbound (tirzepatide) Prescribing Information. FDA.Read Study

    Was this article helpful?

    Keep Reading

    Complete first-month guide comparing semaglutide and tirzepatide. Week-by-week expectations, side effects, weight loss timelines, and success strategies.

    Complete guide to your first month on tirzepatide, including side effects, weight loss expectations, and tips for success.

    Complete guide to safely switching from semaglutide to tirzepatide. Dosing protocols, timeline, managing side effects, and maximizing results.

    Complete guide to your first month on semaglutide, including side effects timeline, weight loss expectations, and tips for success.

    Start your GLP-1 journey — from $99/mo

    Get Started